Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 3/20 | 0.48 |
| ▸ | CTSS | P25774 | 2/20 | 0.47 |
| ▸ | CTSK | P43235 | 1/20 | 0.47 |
| ▸ | KLK7 | P49862 | 1/20 | 0.47 |
| ▸ | KLK5 | Q9Y337 | 1/20 | 0.47 |
| ▸ | CCKBR | P32239 | 2/20 | 0.47 |
| ▸ | PPARG | P37231 | 2/20 | 0.46 |
| ▸ | SYK | P43405 | 1/20 | 0.46 |
| ▸ | ACE | P12821 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24945915 | 0.95 | CCKBR (0.49) | PPARACTSSCTSKKLK7KLK5 | |
| SCHEMBL24946317 | 0.93 | KLK7 (0.45) | PPARACTSSCTSKKLK7KLK5 | |
| SCHEMBL19930033 | 0.92 | SYK (0.48) | CTSSCTSKCCKBRSYK | |
| SCHEMBL16439602 | 0.88 | BCHE (0.47) | PPARACTSSCTSKKLK7KLK5 | |
| SCHEMBL7278249 | 0.87 | CCKBR (0.46) | PPARACTSSCTSKKLK7KLK5 | |
| SCHEMBL7827126 | 0.83 | CTSS (0.52) | PPARACTSSCTSKKLK7KLK5 | |
| SCHEMBL16431333 | 0.83 | CTSS (0.46) | PPARACTSSCTSKPPARGACE | |
| SCHEMBL23512578 | 0.82 | KLK7 (0.51) | PPARACTSSCTSKKLK7KLK5 | |
| SCHEMBL28807338 | 0.82 | KLK7 (0.51) | PPARACTSSCTSKKLK7KLK5 | |
| SCHEMBL29528466 | 0.82 | KLK7 (0.51) | PPARACTSSCTSKKLK7KLK5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023002452-A1 | PROCESS FOR PREPARATION OF TARGETING LIGANDS | Janssen Pharmaceuticals, Inc. (US) | 2023-01-26 | — | — | WO | disclosed |